TELA Bio
TELA | NASDAQ
$0.76
-$0.06 (-7.33%)
At close: Nov 16, 2026, 4:00 PM ET
$0.76
$0.00 (+0.21%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-7.33%
(1D)No price chart data available for 1D timeframe.
Rating
38.8
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #562/1021 (Top 55%)
Key Statistics
Market Data
Market Cap $43.84M
1D Range
0.76 0.81
52W Range
0.56 1.41
Valuation (TTM)
PE -1.03
PB -1.78
EV/EBITDA -2.36
Valuation (NTM)
Forward PE N/A
Forward PEG 0.06
Price Target $2.00
Cash Flow
FCF Yield -78.4%
SBC Adj. FCF Yield -85.0%
SBC Impact -8.4%
Margins
Gross Margin 67.2%
Operating Margin -43.2%
FCF Margin -44.0%
Growth (CAGR)
Revenue 3Y | 5Y 13.8% |
23.9%
Dil EPS 3Y | 5Y 42.9% |
34.4%
FCF 3Y | 5Y 15.6% |
5.9%
Returns
ROA -84.6%
ROE 425.9%
ROIC -102.5%
Financial Health
Net Debt
$33.64M
Current Ratio 0.61
Interest Coverage -8.98
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoratio...
Sector Healthcare
Industry Medical - Devices
Employees 218
IPO Date Nov 7, 2019
Website www.telabio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 10, 2026
EPS
-$0.13
Beat +19.13%
YoY:
+31.58% REV
$18.96M
Miss -5.20%
YoY:
-8.36%Next Earnings
Mar 23, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
4
Consensus
Buy
Price Target
$2.00
Upside
+163.16%
Buy (3)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove TELA